Guidelines for Initiating Sildenafil Therapy in Patients with Erectile Dysfunction

Initial Assessment and Dosing

The American Urological Association recommends oral phosphodiesterase type 5 inhibitors like sildenafil as first-line therapy for erectile dysfunction unless contraindicated 2
The recommended starting dose of sildenafil for ED is 50 mg taken approximately 1 hour before sexual activity, with dose adjustments based on efficacy and tolerability 1, 2
Dosing should be titrated to provide optimal efficacy while minimizing adverse effects - doses can be adjusted up to 100 mg or down to 25 mg 2, 3

Patients should be instructed that sexual stimulation is necessary for the medication to be effective 2, 4
Multiple trials may be required to establish efficacy - patients should try the medication several times before determining it doesn't work 2, 4
Taking sildenafil with a large meal may reduce effectiveness and delay onset of action 2, 4

Patients with cardiovascular disease should be stratified according to risk, with high-risk patients not receiving treatment until cardiac condition stabilizes, and low-risk patients may be considered for treatment 5
Intermediate-risk patients should undergo cardiac evaluation before treatment 5

In patients with mild to moderate hepatic or renal impairment, start with lower doses due to potential for delayed metabolism 2, 4
Sildenafil is generally not recommended in patients with severe renal or liver disease 2, 4
Men with diabetes and post-prostatectomy patients typically have more severe ED at baseline and may respond less robustly to PDE5i therapy 2, 4
In men with ED and testosterone deficiency, combining testosterone therapy with sildenafil may be more effective than sildenafil alone 1, 4

Titrate dose based on patient and partner reports of efficacy, side effects, and acceptance of therapy 2
For patients who don't respond to sildenafil alone, consider combination with other therapies which may provide greater improvements in erectile function 3, 6
If sildenafil is ineffective after multiple properly administered attempts at the maximum tolerated dose, consider alternative ED treatments 2

Not providing adequate instructions on proper use, leading to perceived treatment failures 2, 4
Overlooking the opportunity to assess cardiovascular risk factors, as ED may be an early marker of cardiovascular disease 2
Not considering testosterone deficiency in men with suboptimal response to sildenafil 1, 4
Starting with too high a dose in elderly patients or those with renal/hepatic impairment, increasing the risk of adverse effects 2, 4